actinium Ac 225 rosopatamab tetraxetan
Term · Oncology and biomedicine · MLC-T-ONC-009619
A radioimmunoconjugate consisting of a humanized monoclonal antibody directed against prostate specific membrane antigen (PSMA) labeled with the alpha particle-emitting radioisotope actinium Ac-225, with potential antineoplastic activity. Upon administration, actinium Ac 225 rosopatamab tetraxetan binds to the extracellular domain of PSMA with high affinity, thereby delivering alpha radiation to PSMA expressing cells. PSMA, a type II membrane protein expressed in all types of prostatic tissues, is often overexpressed in tumor cells.
| Identifier | MLC-T-ONC-009619 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 225Ac-J591 |
| Synonyms | Ac 225 monoclonal antibody J591; Ac 225 MOAB J591; actinium Ac-225 anti-prostate-specific membrane antigen monoclonal antibody J591; actinium Ac-225 anti-PSMA monoclonal antibody J591 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009619",
"term": "actinium Ac 225 rosopatamab tetraxetan",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate consisting of a humanized monoclonal antibody directed against prostate specific membrane antigen (PSMA) labeled with the alpha particle-emitting radioisotope actinium Ac-225, with potential antineoplastic activity. Upon administration, actinium Ac 225 rosopatamab tetraxetan binds to the extracellular domain of PSMA with high affinity, thereby delivering alpha radiation to PSMA expressing cells. PSMA, a type II membrane protein expressed in all types of prostatic tissues, is often overexpressed in tumor cells.",
"abbreviation": "225Ac-J591",
"synonyms": [
"Ac 225 monoclonal antibody J591",
"Ac 225 MOAB J591",
"actinium Ac-225 anti-prostate-specific membrane antigen monoclonal antibody J591",
"actinium Ac-225 anti-PSMA monoclonal antibody J591"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/actinium-ac-225-rosopatamab-tetraxetan/"
}
Record 296 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.